Results 111 to 120 of about 166,777 (257)

A Preshistoric Dog Burial from the Intermediate Period at CA-ORA-1055, Laguna Canyon, Orange County, California [PDF]

open access: yes, 2014
The skeleton of an aboriginal dog was exhumed at CA‐ORA‐1055, a lakeside camp site, whose occupants focused on local resource extraction in Laguna Canyon, central Orange County, California. The burial dates to the later Intermediate Period.
Buffington, Kevin   +1 more
core  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Preshistoric Dog Burial from the Intermediate Period at CA-ORA-1055, Laguna Canyon, Orange County, California

open access: yes, 2014
The skeleton of an aboriginal dog was exhumed at CA‐ORA‐1055, a lakeside camp site, whose occupants focused on local resource extraction in Laguna Canyon, central Orange County, California. The burial dates to the later Intermediate Period.
Langenwalter, Paul E.
core  

Associations of personal and family preeclampsia history with the risk for early-, intermediate-, and late-onset preeclampsia

open access: yes, 2014
Preeclampsia recurs in individuals and clusters in families, but its heritable aspects are not thoroughly understood. Its heritability is estimated to be 30% to 55%; its etiology likely involves both maternal and paternal genetic factors along with ...
Boyd, Heather A.   +3 more
core   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Through change and tradition : the rise of Thebes during the Second Intermediate Period

open access: yes, 2011
This article attempts a historical, archaeological and social analysis of the rule of Thebes at the end of the Second Intermediate Period, through the diachronic survey of the funerary culture. At the end of the Middle Kingdom, the northern tradition
MINIACI, GIANLUCA
core  

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos   +9 more
wiley   +1 more source

Territoriality and fortifications between the Pacifiic coast and the meridional andean altiplano to the late intermediate period (1100-1450 AD)

open access: yes, 2021
Cette thèse a pour objectif de comprendre les modalités de l'occupation des régions impliquées dans la complémentarité écologique andine durant une époque considérée comme particulièrement conflictuelle : l'Intermédiaire Récent (1100- 1450 Apr.
Housse, Romuald
core  

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy